HB117 — Establish opioid antagonist therapy for supervised offenders

HB117 — Establish opioid antagonist therapy for supervised offenders · Informed CitizenryHB117 establishes a statewide pilot program beginning July 1, 2018, to provide long-acting opioid antagonist therapy (such as naltrexone) to offenders convicted of opioid-related offenses who are b…Open in Informed Citizenry